Replies to post #12066 on Intellect Neurosciences Inc. (fka ILNS)

[qotsa55]

mkaiz...Of course if they could advance their pipeline it would help them in both partnerships and a complete sale. Them getting OX1 through phase 1 trials is how they landed the deal with Viopharma. The problem even with a settlement or them winning a lenghty trial that I believe they will receive between 2.5 to 4.5 million for is that still isn't enough to bring any of their compounds through phase1. You would still have the same problem, money being spent on trials would lead the company to dump more shares for money for day to day operations. There still isn't anyone at Intellect to oversee and get these trials going...no CSO, CEO, CFO...etc. I think with what Intellect has right now is enough for a Large Pharma to spend a little cash and pick this company up. IMO